186 related articles for article (PubMed ID: 17096083)
1. Noradrenergic antagonism of the P13 and N40 components of the rat auditory evoked potential.
Keedy SK; Marlow-O'Connor M; Beenken B; Dorflinger J; Abel M; Erwin RJ
Psychopharmacology (Berl); 2007 Jan; 190(1):117-25. PubMed ID: 17096083
[TBL] [Abstract][Full Text] [Related]
2. Neurochemical modulation of the P13 midlatency auditory evoked potential in the rat.
Miyazato H; Skinner RD; Garcia-Rill E
Neuroscience; 1999; 92(3):911-20. PubMed ID: 10426532
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
Moxon KA; Gerhardt GA; Adler LE
Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
[TBL] [Abstract][Full Text] [Related]
4. Locus coeruleus involvement in the effects of immobilization stress on the p13 midlatency auditory evoked potential in the rat.
Miyazato H; Skinner RD; Garcia-Rill E
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Oct; 24(7):1177-201. PubMed ID: 11131179
[TBL] [Abstract][Full Text] [Related]
5. Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism.
Simosky JK; Stevens KE; Adler LE; Freedman R
Psychopharmacology (Berl); 2003 Feb; 165(4):386-96. PubMed ID: 12459928
[TBL] [Abstract][Full Text] [Related]
6. Alpha2-noradrenergic effects on ERP and behavioral indices of auditory information processing.
Turetsky BI; Fein G
Psychophysiology; 2002 Mar; 39(2):147-57. PubMed ID: 12212663
[TBL] [Abstract][Full Text] [Related]
7. Yohimbine impairs P50 auditory sensory gating in normal subjects.
Adler LE; Hoffer L; Nagamoto HT; Waldo MC; Kisley MA; Giffith JM
Neuropsychopharmacology; 1994 Jul; 10(4):249-57. PubMed ID: 7945735
[TBL] [Abstract][Full Text] [Related]
8. Effects of NMDA and GABA-A Receptor Antagonism on Auditory Steady-State Synchronization in Awake Behaving Rats.
Sullivan EM; Timi P; Hong LE; O'Donnell P
Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu118. PubMed ID: 25556198
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory control of sensory gating in a computer model of the CA3 region of the hippocampus.
Moxon KA; Gerhardt GA; Gulinello M; Adler LE
Biol Cybern; 2003 Apr; 88(4):247-64. PubMed ID: 12690484
[TBL] [Abstract][Full Text] [Related]
10. Disruption of sensory gating by the alpha 2 selective noradrenergic antagonist yohimbine.
Stevens KE; Meltzer J; Rose GM
Biol Psychiatry; 1993 Jan; 33(2):130-2. PubMed ID: 8439602
[No Abstract] [Full Text] [Related]
11. Metabotropic glutamate receptors subtype 5 are necessary for the enhancement of auditory evoked potentials in the lateral nucleus of the amygdala by tetanic stimulation of the auditory thalamus.
Zheng J; Wu X; Li L
Neuroscience; 2008 Mar; 152(1):254-64. PubMed ID: 18065158
[TBL] [Abstract][Full Text] [Related]
12. Auditory sensory gating in hippocampus and reticular thalamic neurons in anesthetized rats.
Krause M; Hoffmann WE; Hajós M
Biol Psychiatry; 2003 Feb; 53(3):244-53. PubMed ID: 12559658
[TBL] [Abstract][Full Text] [Related]
13. Auditory-evoked response of the cortex after yohimbine administration: phase advance effect of central noradrenergic activation.
Shinba T; Ando Y; Ozawa N; Yamamoto K
Brain Res Bull; 1992 Mar; 28(3):463-71. PubMed ID: 1591603
[TBL] [Abstract][Full Text] [Related]
14. Effect of tumor necrosis factor-alpha on the reciprocal G-protein-induced regulation of norepinephrine release by the alpha2-adrenergic receptor.
Reynolds JL; Ignatowski TA; Spengler RN
J Neurosci Res; 2005 Mar; 79(6):779-87. PubMed ID: 15672410
[TBL] [Abstract][Full Text] [Related]
15. Sensory gating of the P13 midlatency auditory evoked potential and the startle response in the rat.
Miyazato H; Skinner RD; Garcia-Rill E
Brain Res; 1999 Mar; 822(1-2):60-71. PubMed ID: 10082884
[TBL] [Abstract][Full Text] [Related]
16. Yohimbine prevents morphine-induced changes of glial fibrillary acidic protein in brainstem and alpha2-adrenoceptor gene expression in hippocampus.
Alonso E; Garrido E; Díez-Fernández C; Pérez-García C; Herradón G; Ezquerra L; Deuel TF; Alguacil LF
Neurosci Lett; 2007 Jan; 412(2):163-7. PubMed ID: 17123717
[TBL] [Abstract][Full Text] [Related]
17. Histological correlates of N40 auditory evoked potentials in adult rats after neonatal ventral hippocampal lesion: animal model of schizophrenia.
Romero-Pimentel AL; Vázquez-Roque RA; Camacho-Abrego I; Hoffman KL; Linares P; Flores G; Manjarrez E
Schizophr Res; 2014 Nov; 159(2-3):450-7. PubMed ID: 25261883
[TBL] [Abstract][Full Text] [Related]
18. 5-Hydroxytryptamine2 receptors modulate auditory filtering in the rat.
Johnson RG; Stevens KE; Rose GM
J Pharmacol Exp Ther; 1998 May; 285(2):643-50. PubMed ID: 9580608
[TBL] [Abstract][Full Text] [Related]
19. Noradrenergic modulation of activity in a vocal control nucleus in vitro.
Solis MM; Perkel DJ
J Neurophysiol; 2006 Apr; 95(4):2265-76. PubMed ID: 16371453
[TBL] [Abstract][Full Text] [Related]
20. Tone-evoked oscillations in the rat auditory cortex result from interactions between the thalamus and reticular nucleus.
Cotillon N; Edeline JM
Eur J Neurosci; 2000 Oct; 12(10):3637-50. PubMed ID: 11029634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
